nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC22A5—Dactinomycin—uterine cancer	0.511	1	CbGbCtD
Cefepime—SLC15A1—epithelium—uterine cancer	0.00409	0.0885	CbGeAlD
Cefepime—SLC15A1—renal system—uterine cancer	0.00379	0.0821	CbGeAlD
Cefepime—SLC15A1—endometrium—uterine cancer	0.00367	0.0794	CbGeAlD
Cefepime—SLC15A1—mammalian vulva—uterine cancer	0.00355	0.0768	CbGeAlD
Cefepime—SLC22A5—myometrium—uterine cancer	0.00283	0.0613	CbGeAlD
Cefepime—SLC15A1—vagina—uterine cancer	0.00275	0.0595	CbGeAlD
Cefepime—SLC15A2—uterine cervix—uterine cancer	0.00253	0.0549	CbGeAlD
Cefepime—SLC15A2—renal system—uterine cancer	0.00237	0.0513	CbGeAlD
Cefepime—SLC15A2—endometrium—uterine cancer	0.00229	0.0496	CbGeAlD
Cefepime—SLC22A5—uterine cervix—uterine cancer	0.0022	0.0477	CbGeAlD
Cefepime—SLC22A5—renal system—uterine cancer	0.00206	0.0446	CbGeAlD
Cefepime—SLC22A5—endometrium—uterine cancer	0.00199	0.0432	CbGeAlD
Cefepime—SLC15A2—female reproductive system—uterine cancer	0.0019	0.0411	CbGeAlD
Cefepime—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00397	CcSEcCtD
Cefepime—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00395	CcSEcCtD
Cefepime—Oral candidiasis—Epirubicin—uterine cancer	0.00173	0.00392	CcSEcCtD
Cefepime—SLC15A2—female gonad—uterine cancer	0.00173	0.0374	CbGeAlD
Cefepime—SLC15A2—vagina—uterine cancer	0.00172	0.0372	CbGeAlD
Cefepime—Sepsis—Etoposide—uterine cancer	0.0017	0.00385	CcSEcCtD
Cefepime—Erythema—Progesterone—uterine cancer	0.00168	0.00379	CcSEcCtD
Cefepime—Phlebitis—Etoposide—uterine cancer	0.00166	0.00374	CcSEcCtD
Cefepime—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00373	CcSEcCtD
Cefepime—SLC22A5—female reproductive system—uterine cancer	0.00165	0.0358	CbGeAlD
Cefepime—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.00164	0.0037	CcSEcCtD
Cefepime—Pancytopenia—Dactinomycin—uterine cancer	0.00162	0.00365	CcSEcCtD
Cefepime—Oral candidiasis—Doxorubicin—uterine cancer	0.0016	0.00362	CcSEcCtD
Cefepime—Neutropenia—Dactinomycin—uterine cancer	0.00159	0.0036	CcSEcCtD
Cefepime—Hypercalcaemia—Epirubicin—uterine cancer	0.00158	0.00358	CcSEcCtD
Cefepime—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00354	CcSEcCtD
Cefepime—Anaemia—Progesterone—uterine cancer	0.00155	0.00351	CcSEcCtD
Cefepime—Pneumonia—Dactinomycin—uterine cancer	0.00153	0.00345	CcSEcCtD
Cefepime—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00344	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00151	0.0034	CcSEcCtD
Cefepime—SLC22A5—female gonad—uterine cancer	0.0015	0.0325	CbGeAlD
Cefepime—SLC22A5—vagina—uterine cancer	0.00149	0.0323	CbGeAlD
Cefepime—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00337	CcSEcCtD
Cefepime—Hypercalcaemia—Doxorubicin—uterine cancer	0.00147	0.00331	CcSEcCtD
Cefepime—Convulsion—Progesterone—uterine cancer	0.00145	0.00329	CcSEcCtD
Cefepime—Agranulocytosis—Dactinomycin—uterine cancer	0.00142	0.0032	CcSEcCtD
Cefepime—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00318	CcSEcCtD
Cefepime—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00316	CcSEcCtD
Cefepime—Confusional state—Progesterone—uterine cancer	0.00138	0.00312	CcSEcCtD
Cefepime—Anaphylactic shock—Progesterone—uterine cancer	0.00137	0.0031	CcSEcCtD
Cefepime—Infection—Progesterone—uterine cancer	0.00136	0.00308	CcSEcCtD
Cefepime—Shock—Progesterone—uterine cancer	0.00135	0.00305	CcSEcCtD
Cefepime—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00298	CcSEcCtD
Cefepime—Erythema multiforme—Dactinomycin—uterine cancer	0.00129	0.00291	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00128	0.0029	CcSEcCtD
Cefepime—Extravasation—Epirubicin—uterine cancer	0.00126	0.00285	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00126	0.00284	CcSEcCtD
Cefepime—Vasodilation—Epirubicin—uterine cancer	0.00125	0.00283	CcSEcCtD
Cefepime—Vasodilation procedure—Epirubicin—uterine cancer	0.00125	0.00283	CcSEcCtD
Cefepime—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00283	CcSEcCtD
Cefepime—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00281	CcSEcCtD
Cefepime—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00279	CcSEcCtD
Cefepime—Paraesthesia—Progesterone—uterine cancer	0.00123	0.00278	CcSEcCtD
Cefepime—Chills—Dactinomycin—uterine cancer	0.00122	0.00276	CcSEcCtD
Cefepime—Dyspnoea—Progesterone—uterine cancer	0.00122	0.00276	CcSEcCtD
Cefepime—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00276	CcSEcCtD
Cefepime—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00275	CcSEcCtD
Cefepime—Hypocalcaemia—Epirubicin—uterine cancer	0.0012	0.00272	CcSEcCtD
Cefepime—Erythema—Dactinomycin—uterine cancer	0.00119	0.00268	CcSEcCtD
Cefepime—Gastrointestinal disorder—Progesterone—uterine cancer	0.00118	0.00267	CcSEcCtD
Cefepime—Constipation—Progesterone—uterine cancer	0.00117	0.00265	CcSEcCtD
Cefepime—Pain—Progesterone—uterine cancer	0.00117	0.00265	CcSEcCtD
Cefepime—Pancytopenia—Etoposide—uterine cancer	0.00117	0.00264	CcSEcCtD
Cefepime—Extravasation—Doxorubicin—uterine cancer	0.00117	0.00264	CcSEcCtD
Cefepime—Vasodilation procedure—Doxorubicin—uterine cancer	0.00116	0.00262	CcSEcCtD
Cefepime—Vasodilation—Doxorubicin—uterine cancer	0.00116	0.00262	CcSEcCtD
Cefepime—Neutropenia—Etoposide—uterine cancer	0.00115	0.0026	CcSEcCtD
Cefepime—Inflammation—Epirubicin—uterine cancer	0.00114	0.00257	CcSEcCtD
Cefepime—Feeling abnormal—Progesterone—uterine cancer	0.00113	0.00255	CcSEcCtD
Cefepime—Gastrointestinal pain—Progesterone—uterine cancer	0.00112	0.00253	CcSEcCtD
Cefepime—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00252	CcSEcCtD
Cefepime—Hypocalcaemia—Doxorubicin—uterine cancer	0.00111	0.00252	CcSEcCtD
Cefepime—SLC15A2—lymph node—uterine cancer	0.00111	0.024	CbGeAlD
Cefepime—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.0025	CcSEcCtD
Cefepime—Pneumonia—Etoposide—uterine cancer	0.00111	0.0025	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.0011	0.00249	CcSEcCtD
Cefepime—Vaginal inflammation—Epirubicin—uterine cancer	0.0011	0.00249	CcSEcCtD
Cefepime—Anaemia—Dactinomycin—uterine cancer	0.0011	0.00248	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00109	0.00246	CcSEcCtD
Cefepime—Urticaria—Progesterone—uterine cancer	0.00109	0.00246	CcSEcCtD
Cefepime—Abdominal pain—Progesterone—uterine cancer	0.00108	0.00245	CcSEcCtD
Cefepime—Body temperature increased—Progesterone—uterine cancer	0.00108	0.00245	CcSEcCtD
Cefepime—Renal failure—Etoposide—uterine cancer	0.00108	0.00244	CcSEcCtD
Cefepime—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00242	CcSEcCtD
Cefepime—Leukopenia—Dactinomycin—uterine cancer	0.00106	0.0024	CcSEcCtD
Cefepime—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.0024	CcSEcCtD
Cefepime—Colitis—Epirubicin—uterine cancer	0.00106	0.00239	CcSEcCtD
Cefepime—Candida infection—Epirubicin—uterine cancer	0.00105	0.00238	CcSEcCtD
Cefepime—Inflammation—Doxorubicin—uterine cancer	0.00105	0.00237	CcSEcCtD
Cefepime—Vaginal infection—Epirubicin—uterine cancer	0.00104	0.00235	CcSEcCtD
Cefepime—Aplastic anaemia—Epirubicin—uterine cancer	0.00103	0.00234	CcSEcCtD
Cefepime—Agranulocytosis—Etoposide—uterine cancer	0.00103	0.00232	CcSEcCtD
Cefepime—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00231	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.00102	0.0023	CcSEcCtD
Cefepime—Vaginal inflammation—Doxorubicin—uterine cancer	0.00102	0.0023	CcSEcCtD
Cefepime—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00229	CcSEcCtD
Cefepime—Hypersensitivity—Progesterone—uterine cancer	0.00101	0.00228	CcSEcCtD
Cefepime—Coma—Epirubicin—uterine cancer	0.00101	0.00227	CcSEcCtD
Cefepime—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000986	0.00223	CcSEcCtD
Cefepime—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000981	0.00222	CcSEcCtD
Cefepime—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000981	0.00222	CcSEcCtD
Cefepime—Colitis—Doxorubicin—uterine cancer	0.000978	0.00221	CcSEcCtD
Cefepime—Candida infection—Doxorubicin—uterine cancer	0.000973	0.0022	CcSEcCtD
Cefepime—Pruritus—Progesterone—uterine cancer	0.000969	0.00219	CcSEcCtD
Cefepime—SLC22A5—lymph node—uterine cancer	0.000966	0.0209	CbGeAlD
Cefepime—Infection—Dactinomycin—uterine cancer	0.000962	0.00217	CcSEcCtD
Cefepime—Vaginal infection—Doxorubicin—uterine cancer	0.000962	0.00217	CcSEcCtD
Cefepime—Aplastic anaemia—Doxorubicin—uterine cancer	0.000957	0.00216	CcSEcCtD
Cefepime—Sepsis—Epirubicin—uterine cancer	0.000956	0.00216	CcSEcCtD
Cefepime—Thrombocytopenia—Dactinomycin—uterine cancer	0.000948	0.00214	CcSEcCtD
Cefepime—Diarrhoea—Progesterone—uterine cancer	0.000937	0.00212	CcSEcCtD
Cefepime—Erythema multiforme—Etoposide—uterine cancer	0.000933	0.00211	CcSEcCtD
Cefepime—Coma—Doxorubicin—uterine cancer	0.000931	0.0021	CcSEcCtD
Cefepime—Phlebitis—Epirubicin—uterine cancer	0.000928	0.0021	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000919	0.00208	CcSEcCtD
Cefepime—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000915	0.00207	CcSEcCtD
Cefepime—Hepatic function abnormal—Epirubicin—uterine cancer	0.000915	0.00207	CcSEcCtD
Cefepime—Dizziness—Progesterone—uterine cancer	0.000906	0.00205	CcSEcCtD
Cefepime—Hepatic failure—Epirubicin—uterine cancer	0.000889	0.00201	CcSEcCtD
Cefepime—Chills—Etoposide—uterine cancer	0.000885	0.002	CcSEcCtD
Cefepime—Sepsis—Doxorubicin—uterine cancer	0.000884	0.002	CcSEcCtD
Cefepime—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000878	0.00198	CcSEcCtD
Cefepime—Vomiting—Progesterone—uterine cancer	0.000871	0.00197	CcSEcCtD
Cefepime—Rash—Progesterone—uterine cancer	0.000864	0.00195	CcSEcCtD
Cefepime—Dermatitis—Progesterone—uterine cancer	0.000863	0.00195	CcSEcCtD
Cefepime—Phlebitis—Doxorubicin—uterine cancer	0.000858	0.00194	CcSEcCtD
Cefepime—Headache—Progesterone—uterine cancer	0.000858	0.00194	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.00085	0.00192	CcSEcCtD
Cefepime—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000849	0.00192	CcSEcCtD
Cefepime—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000846	0.00191	CcSEcCtD
Cefepime—Dysgeusia—Etoposide—uterine cancer	0.000841	0.0019	CcSEcCtD
Cefepime—Renal impairment—Epirubicin—uterine cancer	0.00084	0.0019	CcSEcCtD
Cefepime—Pain—Dactinomycin—uterine cancer	0.000828	0.00187	CcSEcCtD
Cefepime—Hepatic failure—Doxorubicin—uterine cancer	0.000823	0.00186	CcSEcCtD
Cefepime—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000821	0.00186	CcSEcCtD
Cefepime—Nausea—Progesterone—uterine cancer	0.000814	0.00184	CcSEcCtD
Cefepime—Feeling abnormal—Dactinomycin—uterine cancer	0.000798	0.0018	CcSEcCtD
Cefepime—Anaemia—Etoposide—uterine cancer	0.000794	0.00179	CcSEcCtD
Cefepime—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000792	0.00179	CcSEcCtD
Cefepime—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000789	0.00178	CcSEcCtD
Cefepime—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000783	0.00177	CcSEcCtD
Cefepime—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000782	0.00177	CcSEcCtD
Cefepime—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000778	0.00176	CcSEcCtD
Cefepime—Renal impairment—Doxorubicin—uterine cancer	0.000777	0.00176	CcSEcCtD
Cefepime—Leukopenia—Etoposide—uterine cancer	0.000769	0.00174	CcSEcCtD
Cefepime—Abdominal pain—Dactinomycin—uterine cancer	0.000765	0.00173	CcSEcCtD
Cefepime—Body temperature increased—Dactinomycin—uterine cancer	0.000765	0.00173	CcSEcCtD
Cefepime—Convulsion—Etoposide—uterine cancer	0.000744	0.00168	CcSEcCtD
Cefepime—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000737	0.00167	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00072	0.00163	CcSEcCtD
Cefepime—Hypersensitivity—Dactinomycin—uterine cancer	0.000713	0.00161	CcSEcCtD
Cefepime—Confusional state—Etoposide—uterine cancer	0.000707	0.0016	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000705	0.00159	CcSEcCtD
Cefepime—Anaphylactic shock—Etoposide—uterine cancer	0.000701	0.00158	CcSEcCtD
Cefepime—Infection—Etoposide—uterine cancer	0.000696	0.00157	CcSEcCtD
Cefepime—Thrombocytopenia—Etoposide—uterine cancer	0.000686	0.00155	CcSEcCtD
Cefepime—Eosinophilia—Epirubicin—uterine cancer	0.000684	0.00155	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000666	0.00151	CcSEcCtD
Cefepime—Bronchitis—Epirubicin—uterine cancer	0.000664	0.0015	CcSEcCtD
Cefepime—Diarrhoea—Dactinomycin—uterine cancer	0.000663	0.0015	CcSEcCtD
Cefepime—Pancytopenia—Epirubicin—uterine cancer	0.000656	0.00148	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000652	0.00147	CcSEcCtD
Cefepime—Neutropenia—Epirubicin—uterine cancer	0.000646	0.00146	CcSEcCtD
Cefepime—Eosinophilia—Doxorubicin—uterine cancer	0.000633	0.00143	CcSEcCtD
Cefepime—Paraesthesia—Etoposide—uterine cancer	0.000629	0.00142	CcSEcCtD
Cefepime—Dyspnoea—Etoposide—uterine cancer	0.000625	0.00141	CcSEcCtD
Cefepime—Pneumonia—Epirubicin—uterine cancer	0.00062	0.0014	CcSEcCtD
Cefepime—Vomiting—Dactinomycin—uterine cancer	0.000616	0.00139	CcSEcCtD
Cefepime—Bronchitis—Doxorubicin—uterine cancer	0.000615	0.00139	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000611	0.00138	CcSEcCtD
Cefepime—Rash—Dactinomycin—uterine cancer	0.000611	0.00138	CcSEcCtD
Cefepime—Pancytopenia—Doxorubicin—uterine cancer	0.000607	0.00137	CcSEcCtD
Cefepime—Renal failure—Epirubicin—uterine cancer	0.000605	0.00137	CcSEcCtD
Cefepime—Gastrointestinal disorder—Etoposide—uterine cancer	0.000605	0.00137	CcSEcCtD
Cefepime—Pain—Etoposide—uterine cancer	0.000599	0.00135	CcSEcCtD
Cefepime—Constipation—Etoposide—uterine cancer	0.000599	0.00135	CcSEcCtD
Cefepime—Urinary tract infection—Epirubicin—uterine cancer	0.000599	0.00135	CcSEcCtD
Cefepime—Neutropenia—Doxorubicin—uterine cancer	0.000598	0.00135	CcSEcCtD
Cefepime—Feeling abnormal—Etoposide—uterine cancer	0.000578	0.00131	CcSEcCtD
Cefepime—Nausea—Dactinomycin—uterine cancer	0.000575	0.0013	CcSEcCtD
Cefepime—Agranulocytosis—Epirubicin—uterine cancer	0.000575	0.0013	CcSEcCtD
Cefepime—Pneumonia—Doxorubicin—uterine cancer	0.000573	0.0013	CcSEcCtD
Cefepime—Gastrointestinal pain—Etoposide—uterine cancer	0.000573	0.0013	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000565	0.00128	CcSEcCtD
Cefepime—Renal failure—Doxorubicin—uterine cancer	0.00056	0.00127	CcSEcCtD
Cefepime—Urticaria—Etoposide—uterine cancer	0.000557	0.00126	CcSEcCtD
Cefepime—Haemoglobin—Epirubicin—uterine cancer	0.000556	0.00126	CcSEcCtD
Cefepime—Abdominal pain—Etoposide—uterine cancer	0.000554	0.00125	CcSEcCtD
Cefepime—Body temperature increased—Etoposide—uterine cancer	0.000554	0.00125	CcSEcCtD
Cefepime—Urinary tract infection—Doxorubicin—uterine cancer	0.000554	0.00125	CcSEcCtD
Cefepime—Haemorrhage—Epirubicin—uterine cancer	0.000553	0.00125	CcSEcCtD
Cefepime—Agranulocytosis—Doxorubicin—uterine cancer	0.000532	0.0012	CcSEcCtD
Cefepime—Erythema multiforme—Epirubicin—uterine cancer	0.000523	0.00118	CcSEcCtD
Cefepime—Hypersensitivity—Etoposide—uterine cancer	0.000516	0.00117	CcSEcCtD
Cefepime—Haemoglobin—Doxorubicin—uterine cancer	0.000514	0.00116	CcSEcCtD
Cefepime—Haemorrhage—Doxorubicin—uterine cancer	0.000512	0.00116	CcSEcCtD
Cefepime—Chills—Epirubicin—uterine cancer	0.000496	0.00112	CcSEcCtD
Cefepime—Pruritus—Etoposide—uterine cancer	0.000496	0.00112	CcSEcCtD
Cefepime—Erythema multiforme—Doxorubicin—uterine cancer	0.000484	0.00109	CcSEcCtD
Cefepime—Erythema—Epirubicin—uterine cancer	0.000481	0.00109	CcSEcCtD
Cefepime—Diarrhoea—Etoposide—uterine cancer	0.00048	0.00108	CcSEcCtD
Cefepime—Dysgeusia—Epirubicin—uterine cancer	0.000471	0.00107	CcSEcCtD
Cefepime—Dizziness—Etoposide—uterine cancer	0.000463	0.00105	CcSEcCtD
Cefepime—Chills—Doxorubicin—uterine cancer	0.000459	0.00104	CcSEcCtD
Cefepime—Vomiting—Etoposide—uterine cancer	0.000446	0.00101	CcSEcCtD
Cefepime—Erythema—Doxorubicin—uterine cancer	0.000445	0.00101	CcSEcCtD
Cefepime—Anaemia—Epirubicin—uterine cancer	0.000445	0.00101	CcSEcCtD
Cefepime—Agitation—Epirubicin—uterine cancer	0.000442	0.001	CcSEcCtD
Cefepime—Rash—Etoposide—uterine cancer	0.000442	0.000999	CcSEcCtD
Cefepime—Dermatitis—Etoposide—uterine cancer	0.000441	0.000998	CcSEcCtD
Cefepime—Headache—Etoposide—uterine cancer	0.000439	0.000992	CcSEcCtD
Cefepime—Dysgeusia—Doxorubicin—uterine cancer	0.000436	0.000986	CcSEcCtD
Cefepime—Leukopenia—Epirubicin—uterine cancer	0.000431	0.000974	CcSEcCtD
Cefepime—Convulsion—Epirubicin—uterine cancer	0.000417	0.000942	CcSEcCtD
Cefepime—Nausea—Etoposide—uterine cancer	0.000416	0.000941	CcSEcCtD
Cefepime—Anaemia—Doxorubicin—uterine cancer	0.000412	0.00093	CcSEcCtD
Cefepime—Agitation—Doxorubicin—uterine cancer	0.000409	0.000925	CcSEcCtD
Cefepime—Leukopenia—Doxorubicin—uterine cancer	0.000399	0.000901	CcSEcCtD
Cefepime—Confusional state—Epirubicin—uterine cancer	0.000396	0.000895	CcSEcCtD
Cefepime—Anaphylactic shock—Epirubicin—uterine cancer	0.000393	0.000888	CcSEcCtD
Cefepime—Infection—Epirubicin—uterine cancer	0.00039	0.000882	CcSEcCtD
Cefepime—Shock—Epirubicin—uterine cancer	0.000387	0.000873	CcSEcCtD
Cefepime—Convulsion—Doxorubicin—uterine cancer	0.000386	0.000872	CcSEcCtD
Cefepime—Thrombocytopenia—Epirubicin—uterine cancer	0.000385	0.000869	CcSEcCtD
Cefepime—Confusional state—Doxorubicin—uterine cancer	0.000367	0.000828	CcSEcCtD
Cefepime—Anaphylactic shock—Doxorubicin—uterine cancer	0.000363	0.000821	CcSEcCtD
Cefepime—Infection—Doxorubicin—uterine cancer	0.000361	0.000816	CcSEcCtD
Cefepime—Shock—Doxorubicin—uterine cancer	0.000358	0.000808	CcSEcCtD
Cefepime—Thrombocytopenia—Doxorubicin—uterine cancer	0.000356	0.000804	CcSEcCtD
Cefepime—Paraesthesia—Epirubicin—uterine cancer	0.000353	0.000797	CcSEcCtD
Cefepime—Dyspnoea—Epirubicin—uterine cancer	0.00035	0.000791	CcSEcCtD
Cefepime—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000339	0.000766	CcSEcCtD
Cefepime—Pain—Epirubicin—uterine cancer	0.000336	0.000759	CcSEcCtD
Cefepime—Constipation—Epirubicin—uterine cancer	0.000336	0.000759	CcSEcCtD
Cefepime—Paraesthesia—Doxorubicin—uterine cancer	0.000326	0.000738	CcSEcCtD
Cefepime—Dyspnoea—Doxorubicin—uterine cancer	0.000324	0.000732	CcSEcCtD
Cefepime—Feeling abnormal—Epirubicin—uterine cancer	0.000324	0.000732	CcSEcCtD
Cefepime—Gastrointestinal pain—Epirubicin—uterine cancer	0.000321	0.000726	CcSEcCtD
Cefepime—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000314	0.000709	CcSEcCtD
Cefepime—Urticaria—Epirubicin—uterine cancer	0.000312	0.000705	CcSEcCtD
Cefepime—Pain—Doxorubicin—uterine cancer	0.000311	0.000702	CcSEcCtD
Cefepime—Constipation—Doxorubicin—uterine cancer	0.000311	0.000702	CcSEcCtD
Cefepime—Abdominal pain—Epirubicin—uterine cancer	0.000311	0.000702	CcSEcCtD
Cefepime—Body temperature increased—Epirubicin—uterine cancer	0.000311	0.000702	CcSEcCtD
Cefepime—Feeling abnormal—Doxorubicin—uterine cancer	0.0003	0.000677	CcSEcCtD
Cefepime—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000297	0.000672	CcSEcCtD
Cefepime—Hypersensitivity—Epirubicin—uterine cancer	0.000289	0.000654	CcSEcCtD
Cefepime—Urticaria—Doxorubicin—uterine cancer	0.000289	0.000653	CcSEcCtD
Cefepime—Abdominal pain—Doxorubicin—uterine cancer	0.000287	0.000649	CcSEcCtD
Cefepime—Body temperature increased—Doxorubicin—uterine cancer	0.000287	0.000649	CcSEcCtD
Cefepime—Pruritus—Epirubicin—uterine cancer	0.000278	0.000628	CcSEcCtD
Cefepime—Diarrhoea—Epirubicin—uterine cancer	0.000269	0.000607	CcSEcCtD
Cefepime—Hypersensitivity—Doxorubicin—uterine cancer	0.000268	0.000605	CcSEcCtD
Cefepime—Dizziness—Epirubicin—uterine cancer	0.00026	0.000587	CcSEcCtD
Cefepime—Pruritus—Doxorubicin—uterine cancer	0.000257	0.000581	CcSEcCtD
Cefepime—Vomiting—Epirubicin—uterine cancer	0.00025	0.000564	CcSEcCtD
Cefepime—Diarrhoea—Doxorubicin—uterine cancer	0.000249	0.000562	CcSEcCtD
Cefepime—Rash—Epirubicin—uterine cancer	0.000248	0.00056	CcSEcCtD
Cefepime—Dermatitis—Epirubicin—uterine cancer	0.000247	0.000559	CcSEcCtD
Cefepime—Headache—Epirubicin—uterine cancer	0.000246	0.000556	CcSEcCtD
Cefepime—Dizziness—Doxorubicin—uterine cancer	0.00024	0.000543	CcSEcCtD
Cefepime—Nausea—Epirubicin—uterine cancer	0.000233	0.000527	CcSEcCtD
Cefepime—Vomiting—Doxorubicin—uterine cancer	0.000231	0.000522	CcSEcCtD
Cefepime—Rash—Doxorubicin—uterine cancer	0.000229	0.000518	CcSEcCtD
Cefepime—Dermatitis—Doxorubicin—uterine cancer	0.000229	0.000517	CcSEcCtD
Cefepime—Headache—Doxorubicin—uterine cancer	0.000228	0.000515	CcSEcCtD
Cefepime—Nausea—Doxorubicin—uterine cancer	0.000216	0.000488	CcSEcCtD
